Development of novel treatment strategies for inflammatory diseases-similarities and divergence between glucocorticoids and GILZ

Frontiers in Pharmacology

Volumn 5 JUL, Issue , 2014, Pages

  Cheng, Qiang ^a   Morand, Eric ^a   Yang, Yuan Hang ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Anti inflammation; Cell biology; GILZ; Glucocorticoids; Immune response; Inflammation

Indexed keywords

ANTIINFLAMMATORY AGENT; GLUCOCORTICOID; GLUCOCORTICOID INDUCED LEUCINE ZIPPER; GLUCOCORTICOID RECEPTOR; MESSENGER RNA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; CELL LINEAGE; CELL SPECIFICITY; COLITIS; COMPLEX FORMATION; DENDRITIC CELL; DRUG EFFICACY; DRUG RESEARCH; ENDOTHELIUM CELL; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GENE SILENCING; GENE THERAPY; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INFLAMMATORY DISEASE; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE; MESENCHYMAL STEM CELL; MONOCYTE; NONHUMAN; OSTEOBLAST; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SPINAL CORD INJURY; T LYMPHOCYTE ACTIVATION; THYMOCYTE;

EID: 84904730185     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2014.00169     Document Type: Review

References (115)

1. Adcock, I. M., Brown, C. R., Gelder, C. M., Shirasaki, H., Peters, M. J., and Barnes, P. J. (1995). Effects of glucocorticoids on transcription factor activation in human peripheral blood mononuclear cells. Am. J. Physiol. 268(2 Pt 1), C331-C338.
2. Ahdjoudj, S., Lasmoles, F., Oyajobi, B. O., Lomri, A., Delannoy, P., and Marie, P. J. (2001). Reciprocal control of osteoblast/chondroblast and osteoblast/adipocyte differentiation of multipotential clonal human marrow stromal F/STRO-1(+) cells. J. Cell. Biochem. 81, 23-38. doi: 10.1002/1097-4644(20010401)
3. Akune, T., Ohba, S., Kamekura, S., Yamaguchi, M., Chung, U. I., Kubota, N., et al. (2004). PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J. Clin. Invest. 113, 846-855. doi: 10.1172/JCI19900
4. Almawi, W. Y., Beyhum, H. N., Rahme, A. A., and Rieder, M. J. (1996). Regulation of cytokine and cytokine receptor expression by glucocorticoids. J. Leukoc. Biol. 60, 563-572.
5. Antonioli, L., Fornai, M., Colucci, R., Ghisu, N., Da Settimo, F., Natale, G., et al. (2007). Inhibition of adenosine deaminase attenuates inflammation in experimental colitis. J. Pharmacol. Exp. Ther. 322, 435-442. doi: 10.1124/jpet.107.122762
6. Ashwell, J. D., Lu, F. W., and Vacchio, M. S. (2000). Glucocorticoids in T cell development and function. Annu. Rev. Immunol. 18, 309-345. doi: 10.1146/annurev.immunol.18.1.309
7. Asselin-Labat, M. L., Biola-Vidamment, A., Kerbrat, S., Lombes, M., Bertoglio, J., and Pallardy, M. (2005). FoxO3 mediates antagonistic effects of glucocorticoids and interleukin-2 on glucocorticoid-induced leucine zipper expression. Mol. Endocrinol. 19, 1752-1764. doi: 10.1210/me.2004-0206
8. Asselin-Labat, M. L., David, M., Biola-Vidamment, A., Lecoeuche, D., Zennaro, M. C., Bertoglio, J., et al. (2004). GILZ, a new target for the transcription factor FoxO3, protects T lymphocytes from interleukin-2 withdrawal-induced apoptosis. Blood 104, 215-223. doi: 10.1182/blood-2003-12-4295
9. Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., and Karin, M. (1995). Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270, 286-290.
10. Ayroldi, E., Migliorati, G., Bruscoli, S., Marchetti, C., Zollo, O., Cannarile, L., et al. (2001). Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor kappaB. Blood 98, 743-753. doi: 10.1182/blood.V98.3.743
11. Ayroldi, E., and Riccardi, C. (2009). Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action. FASEB J. 23, 3649-3658. doi: 10.1096/fj.09-134684
12. Ayroldi, E., Zollo, O., Bastianelli, A., Marchetti, C., Agostini, M., Di Virgilio, R., et al. (2007). GILZ mediates the antiproliferative activity of glucocorticoids by negative regulation of Ras signaling. J. Clin. Invest. 117, 1605-1615. doi: 10.1172/JCI30724
13. Ayroldi, E., Zollo, O., Macchiarulo, A., Di Marco, B., Marchetti, C., and Riccardi, C. (2002). Glucocorticoid-induced leucine zipper inhibits the Raf-extracellular signal-regulated kinase pathway by binding to Raf-1. Mol. Cell. Biol. 22, 7929-7941. doi: 10.1128/MCB.22.22.7929-7941.2002
14. Barnes, P. J. (2006). How corticosteroids control inflammation: Quintiles Prize Lecture 2005. Br. J. Pharmacol. 148, 245-254. doi: 10.1038/sj.bjp.0706736
15. Baschant, U., Frappart, L., Rauchhaus, U., Bruns, L., Reichardt, H. M., Kamradt, T., et al. (2011). Glucocorticoid therapy of antigen-induced arthritis depends on the dimerized glucocorticoid receptor in T cells. Proc. Natl. Acad. Sci. U.S.A. 108, 19317-19322. doi: 10.1073/pnas.1105857108
16. Beaulieu, E., and Morand, E. F. (2011). Role of GILZ in immune regulation, glucocorticoid actions and rheumatoid arthritis. Nat. Rev. Rheumatol. 7, 340-348. doi: 10.1038/nrrheum.2011.59
17. Beaulieu, E., Ngo, D., Santos, L., Yang, Y. H., Smith, M., Jorgensen, C., et al. (2010). Glucocorticoid-induced leucine zipper is an endogenous antiinflammatory mediator in arthritis. Arthritis Rheum. 62, 2651-2661. doi: 10.1002/art.27566
18. Berkman, N., Jose, P. J., Williams, T. J., Schall, T. J., Barnes, P. J., and Chung, K. F. (1995). Corticosteroid inhibition of macrophage inflammatory protein-1 alpha in human monocytes and alveolar macrophages. Am. J. Physiol. 269(4 Pt 1), L443-L452.
19. Berrebi, D., Bruscoli, S., Cohen, N., Foussat, A., Migliorati, G., Bouchet-Delbos, L., et al. (2003). Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10. Blood 101, 729-738. doi: 10.1182/blood-2002-02-0538
20. Bianchini, R., Nocentini, G., Krausz, L. T., Fettucciari, K., Coaccioli, S., Ronchetti, S., et al. (2006). Modulation of pro- and antiapoptotic molecules in double-positive (CD4+CD8+) thymocytes following dexamethasone treatment. J. Pharmacol. Exp. Ther. 319, 887-897. doi: 10.1124/jpet.106.108480
21. Bruscoli, S., Di Virgilio, R., Donato, V., Velardi, E., Baldoni, M., Marchetti, C., et al. (2006). Genomic and non-genomic effects of different glucocorticoids on mouse thymocyte apoptosis. Eur. J. Pharmacol. 529, 63-70. doi: 10.1016/j.ejphar.2005.10.053
22. Bruscoli, S., Velardi, E., Di Sante, M., Bereshchenko, O., Venanzi, A., Coppo, M., et al. (2012). Long glucocorticoid-induced leucine zipper (L-GILZ) protein interacts with ras protein pathway and contributes to spermatogenesis control. J. Biol. Chem. 287, 1242-1251. doi: 10.1074/jbc.M111.316372
23. Cannarile, L., Cuzzocrea, S., Santucci, L., Agostini, M., Mazzon, E., Esposito, E., et al. (2009). Glucocorticoid-induced leucine zipper is protective in Th1-mediated models of colitis. Gastroenterology 136, 530-541. doi: 10.1053/j.gastro.2008.09.024
24. Cannarile, L., Fallarino, F., Agostini, M., Cuzzocrea, S., Mazzon, E., Vacca, C., et al. (2006). Increased GILZ expression in transgenic mice up-regulates Th-2 lymphokines. Blood 107, 1039-1047. doi: 10.1182/blood-2005-05-2183
25. Cao, L., Qian, L. L., Zhu, Y. R., Guo, C. B., Gong, X. H., and Sun, B. (2003). Regulation of activity of nuclear factor-kappaB and activator protein-1 by nitric oxide, surfactant and glucocorticoids in alveolar macrophages from piglets with acute lung injury. Acta Pharmacol. Sin. 24, 1316-1323.
26. Chen, C. C., and Manning, A. M. (1995). Transcriptional regulation of endothelial cell adhesion molecules: a dominant role for NF-kappa B. Agents Actions Suppl. 47, 135-141.
27. Chen, X., Oppenheim, J. J., Winkler-Pickett, R. T., Ortaldo, J. R., and Howard, O. M. (2006). Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3(+)CD4(+)CD25(+) T regulatory cells in vivo and enhances their capacity to suppress EAE. Eur. J. Immunol. 36, 2139-2149. doi: 10.1002/eji.200635873
28. Cheng, Q., Fan, H., Ngo, D., Beaulieu, E., Leung, P., Lo, C. Y., et al. (2013). GILZ overexpression inhibits endothelial cell adhesive function through regulation of NF-κB and MAPK activity. J. Immunol. 191, 424-433. doi: 10.4049/jimmunol.1202662
29. Cheng, Q., McKeown, S. J., Santos, L., Santiago, F. S., Khachigian, L. M., Morand, E. F., et al. (2010). Macrophage migration inhibitory factor increases leukocyte-endothelial interactions in human endothelial cells via promotion of expression of adhesion molecules. J. Immunol. 185, 1238-1247. doi: 10.4049/jimmunol.0904104
30. Clark, A. R. (2003). MAP kinase phosphatase 1: a novel mediator of biological effects of glucocorticoids? J. Endocrinol. 178, 5-12. doi: 10.1677/joe.0.1780005
31. Clark, A. R., and Belvisi, M. G. (2012). Maps and legends: the quest for dissociated ligands of the glucocorticoid receptor. Pharmacol. Ther. 134, 54-67. doi: 10.1016/j.pharmthera.2011.12.004
32. Cohen, J. J., and Duke, R. C. (1984). Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J. Immunol. 132, 38-42.
33. Cohen, N., Mouly, E., Hamdi, H., Maillot, M. C., Pallardy, M., Godot, V., et al. (2006). GILZ expression in human dendritic cells redirects their maturation and prevents antigen-specific T lymphocyte response. Blood 107, 2037-2044. doi: 10.1182/blood-2005-07-2760
34. D'Adamio, F., Zollo, O., Moraca, R., Ayroldi, E., Bruscoli, S., Bartoli, A., et al. (1997). A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death. Immunity 7, 803-812.
35. Daynes, R. A., and Araneo, B. A. (1989). Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4. Eur. J. Immunol. 19, 2319-2325. doi: 10.1002/eji.1830191221
36. De Bosscher, K., Vanden Berghe, W., and Haegeman, G. (2003). The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. Endocr. Rev. 24, 488-522. doi: 10.1210/er.2002-0006
37. Delfino, D. V., Agostini, M., Spinicelli, S., Vacca, C., and Riccardi, C. (2006). Inhibited cell death, NF-kappaB activity and increased IL-10 in TCR-triggered thymocytes of transgenic mice overexpressing the glucocorticoid-induced protein GILZ. Int. Immunopharmacol. 6, 1126-1134. doi: 10.1016/j.intimp.2006.02.001
38. Delfino, D. V., Agostini, M., Spinicelli, S., Vito, P., and Riccardi, C. (2004). Decrease of Bcl-xL and augmentation of thymocyte apoptosis in GILZ overexpressing transgenic mice. Blood 104, 4134-4141. doi: 10.1182/blood-2004-03-0920
39. Di Marco, B., Massetti, M., Bruscoli, S., Macchiarulo, A., Di Virgilio, R., Velardi, E., et al. (2007). Glucocorticoid-induced leucine zipper (GILZ)/NF-kappaB interaction: role of GILZ homo-dimerization and C-terminal domain. Nucleic Acids Res. 35, 517-528. doi: 10.1093/nar/gkl1080
40. Eddleston, J., Herschbach, J., Wagelie-Steffen, A. L., Christiansen, S. C., and Zuraw, B. L. (2007). The anti-inflammatory effect of glucocorticoids is mediated by glucocorticoid-induced leucine zipper in epithelial cells. J. Allergy Clin. Immunol. 119, 115-122. doi: 10.1016/j.jaci.2006.08.027
41. Esposito, E., Bruscoli, S., Mazzon, E., Paterniti, I., Coppo, M., Velardi, E., et al. (2012). Glucocorticoid-induced leucine zipper (GILZ) over-expression in T lymphocytes inhibits inflammation and tissue damage in spinal cord injury. Neurotherapeutics 9, 210-225. doi: 10.1007/s13311-011-0084-7
42. Fan, H., and Morand, E. F. (2012). Targeting the side effects of steroid therapy in autoimmune diseases: the role of GILZ. Discov. Med. 13, 123-133.
43. Furst, R., Schroeder, T., Eilken, H. M., Bubik, M. F., Kiemer, A. K., Zahler, S., et al. (2007). MAPK phosphatase-1 represents a novel anti-inflammatory target of glucocorticoids in the human endothelium. FASEB J. 21, 74-80. doi: 10.1096/fj.06-6752com
44. Glynne, R., Ghandour, G., Rayner, J., Mack, D. H., and Goodnow, C. C. (2000). B-lymphocyte quiescence, tolerance and activation as viewed by global gene expression profiling on microarrays. Immunol. Rev. 176, 216-246. doi: 10.1034/j.1600-065X.2000.00614.x
45. Godot, V., Garcia, G., Capel, F., Arock, M., Durand-Gasselin, I., Asselin-Labat, M. L., et al. (2006). Dexamethasone and IL-10 stimulate glucocorticoid-induced leucine zipper synthesis by human mast cells. Allergy 61, 886-890. doi: 10.1111/j.1398-9995.2006.01065.x
46. Goodwin, J. E., Feng, Y., Velazquez, H., and Sessa, W. C. (2013). Endothelial glucocorticoid receptor is required for protection against sepsis. Proc. Natl. Acad. Sci. U.S.A. 110, 306-311. doi: 10.1073/pnas.1210200110
47. Grillot, D. A., Merino, R., and Nunez, G. (1995). Bcl-XL displays restricted distribution during T cell development and inhibits multiple forms of apoptosis but not clonal deletion in transgenic mice. J. Exp. Med. 182, 1973-1983.
48. Hackstein, H., and Thomson, A. W. (2004). Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat. Rev. Immunol. 4, 24-34. doi: 10.1038/nri1256
49. Hall, E. D. (2011). Antioxidant therapies for acute spinal cord injury. Neurotherapeutics 8, 152-167. doi: 10.1007/s13311-011-0026-4
50. Hamdi, H., Bigorgne, A., Naveau, S., Balian, A., Bouchet-Delbos, L., Cassard-Doulcier, A. M., et al. (2007a). Glucocorticoid-induced leucine zipper: A key protein in the sensitization of monocytes to lipopolysaccharide in alcoholic hepatitis. Hepatology 46, 1986-1992. doi: 10.1002/hep.21880
51. Hamdi, H., Godot, V., Maillot, M. C., Prejean, M. V., Cohen, N., Krzysiek, R., et al. (2007b). Induction of antigen-specific regulatory T lymphocytes by human dendritic cells expressing the glucocorticoid-induced leucine zipper. Blood 110, 211-219. doi: 10.1182/blood-2006-10-052506
52. Hoppstadter, J., Diesel, B., Eifler, L. K., Schmid, T., Brune, B., and Kiemer, A. K. (2012). Glucocorticoid-induced leucine zipper is downregulated in human alveolar macrophages upon Toll-like receptor activation. Eur. J. Immunol. 42, 1282-1293. doi: 10.1002/eji.201142081
53. Jeon, Y. J., Han, S. H., Lee, Y. W., Lee, M., Yang, K. H., and Kim, H. M. (2000). Dexamethasone inhibits IL-1 beta gene expression in LPS-stimulated RAW 264.7 cells by blocking NF-kappa B/Rel and AP-1 activation. Immunopharmacology 48, 173-183. doi: 10.1016/S0162-3109(00)00199-5
54. Joyce, D. A., Gimblett, G., and Steer, J. H. (2001). Targets of glucocorticoid action on TNF-alpha release by macrophages. Inflamm. Res. 50, 337-340.
55. Khorsandi, L. S., Hashemitabar, M., Orazizadeh, M., and Albughobeish, N. (2008). Dexamethasone effects on fas ligand expression in mouse testicular germ cells. Pak. J. Biol. Sci. 11, 2231-2236. doi: 10.3923/pjbs.2008.2231.2236
56. Kitajima, T., Ariizumi, K., Bergstresser, P. R., and Takashima, A. (1996). A novel mechanism of glucocorticoid-induced immune suppression: the inhibiton of T cell-mediated terminal maturation of a murine dendritic cell line. J. Clin. Invest. 98, 142-147. doi: 10.1172/JCI118759
57. Kleiman, A., Hubner, S., Rodriguez Parkitna, J. M., Neumann, A., Hofer, S., Weigand, M. A., et al. (2012). Glucocorticoid receptor dimerization is required for survival in septic shock via suppression of interleukin-1 in macrophages. FASEB J. 26, 722-729. doi: 10.1096/fj.11-192112
58. Kuldo, J. M., Westra, J., Asgeirsdottir, S. A., Kok, R. J., Oosterhuis, K., Rots, M. G., et al. (2005). Differential effects of NF-?B and p38 MAPK inhibitors and combinations thereof on TNF-a- and IL-1ß-induced proinflammatory status of endothelial cells in vitro. Am. J. Physiol. Cell Physiol. 289, C1229-C1239. doi: 10.1152/ajpcell.00620.2004
59. Kunicka, J. E., Talle, M. A., Denhardt, G. H., Brown, M., Prince, L. A., and Goldstein, G. (1993). Immunosuppression by glucocorticoids: inhibition of production of multiple lymphokines by in vivo administration of dexamethasone. Cell. Immunol. 149, 39-49. doi: 10.1006/cimm.1993.1134
60. Latre de Late, P., Pepin, A., Assaf-Vandecasteele, H., Espinasse, C., Nicolas, V., Asselin-Labat, M. L., et al. (2010). Glucocorticoid-induced leucine zipper (GILZ) promotes the nuclear exclusion of FOXO3 in a Crm1-dependent manner. J. Biol. Chem. 285, 5594-5605. doi: 10.1074/jbc.M109.068346
61. Ley, K., Laudanna, C., Cybulsky, M. I., and Nourshargh, S. (2007). Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7, 678-689. doi: 10.1038/nri2156
62. Liberman, A. C., Refojo, D., Antunica-Noguerol, M., Holsboer, F., and Arzt, E. (2012). Underlying mechanisms of cAMP- and glucocorticoid-mediated inhibition of FasL expression in activation-induced cell death. Mol. Immunol. 50, 220-235. doi: 10.1016/j.molimm.2012.01.008
63. Marfaing-Koka, A., Maravic, M., Humbert, M., Galanaud, P., and Emilie, D. (1996). Contrasting effects of IL-4, IL-10 and corticosteroids on RANTES production by human monocytes. Int. Immunol. 8, 1587-1594.
64. McKay, L. I., and Cidlowski, J. A. (1999). Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. Endocr. Rev. 20, 435-459.
65. McKinley, L., Alcorn, J. F., Peterson, A., Dupont, R. B., Kapadia, S., Logar, A., et al. (2008). TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J. Immunol. 181, 4089-4097. doi: 10.4049/jimmunol.181.6.4089
66. Mittelstadt, P. R., and Ashwell, J. D. (2001). Inhibition of AP-1 by the glucocorticoid-inducible protein GILZ. J. Biol. Chem. 276, 29603-29610. doi: 10.1074/jbc.M101522200
67. Mittelstadt, P. R., Monteiro, J. P., and Ashwell, J. D. (2012). Thymocyte responsiveness to endogenous glucocorticoids is required for immunological fitness. J. Clin. Invest. 122, 2384-2394. doi: 10.1172/JCI63067
68. Miyaura, H., and Iwata, M. (2002). Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids. J. Immunol. 168, 1087-1094. doi: 10.4049/jimmunol.168.3.1087
69. Mukaida, N., Zachariae, C. C., Gusella, G. L., and Matsushima, K. (1991). Dexamethasone inhibits the induction of monocyte chemotactic-activating factor production by IL-1 or tumor necrosis factor. J. Immunol. 146, 1212-1215.
70. Nanzer, A. M., Chambers, E. S., Ryanna, K., Richards, D. F., Black, C., Timms, P. M., et al. (2013). Enhanced production of IL-17A in patients with severe asthma is inhibited by 1alpha,25-dihydroxyvitamin D3 in a glucocorticoid-independent fashion. J. Allergy Clin. Immunol. 132, 297-304.e3. doi: 10.1016/j.jaci.2013.03.037
71. Newton, R. (2000). Molecular mechanisms of glucocorticoid action: what is important? Thorax 55, 603-613. doi: 10.1136/thorax.55.7.603
72. Ngo, D., Beaulieu, E., Gu, R., Leaney, A., Santos, L., Fan, H., et al. (2013a). Divergent effects of endogenous and exogenous glucocorticoid-induced leucine zipper in animal models of inflammation and arthritis. Arthritis Rheum. 65, 1203-1212. doi: 10.1002/art.37858
73. Ngo, D., Cheng, Q., AE, O. C., Deboer, K. D., Lo, C. Y., Beaulieu, E., et al. (2013b). Glucocorticoid-induced leucine zipper (GILZ) regulates testicular FOXO1 activity and spermatogonial stem cell (SSC) function. PLoS ONE 8:e59149. doi: 10.1371/journal.pone.0059149
74. Nixon, M., Andrew, R., and Chapman, K. E. (2013). It takes two to tango: dimerisation of glucocorticoid receptor and its anti-inflammatory functions. Steroids 78, 59-68. doi: 10.1016/j.steroids.2012.09.013
75. Orazizadeh, M., Khorsandi, L. S., and Hashemitabar, M. (2010). Toxic effects of dexamethasone on mouse testicular germ cells. Andrologia 42, 247-253. doi: 10.1111/j.1439-0272.2009.00985.x
76. Paliogianni, F., Raptis, A., Ahuja, S. S., Najjar, S. M., and Boumpas, D. T. (1993). Negative transcriptional regulation of human interleukin 2 (IL-2) gene by glucocorticoids through interference with nuclear transcription factors AP-1 and NF-AT. J. Clin. Invest. 91, 1481-1489. doi: 10.1172/JCI116353
77. Pan, L. L., Liu, X. H., Gong, Q. H., Wu, D., and Zhu, Y. Z. (2011). Hydrogen sulfide attenuated tumor necrosis factor-alpha-induced inflammatory signaling and dysfunction in vascular endothelial cells. PLoS ONE 6:e19766. doi: 10.1371/journal.pone.0019766
78. Patel, H. B., Kornerup, K. N., Sampaio, A. L., D'Acquisto, F., Seed, M. P., Girol, A. P., et al. (2012). The impact of endogenous annexin A1 on glucocorticoid control of inflammatory arthritis. Ann. Rheum. Dis. 71, 1872-1880. doi: 10.1136/annrheumdis-2011-201180
79. Perretti, M., and D'Acquisto, F. (2009). Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat. Rev. Immunol. 9, 62-70. doi: 10.1038/nri2470
80. Pinheiro, I., Dejager, L., Petta, I., Vandevyver, S., Puimege, L., Mahieu, T., et al. (2013). LPS resistance of SPRET/Ei mice is mediated by Gilz, encoded by the Tsc22d3 gene on the X chromosome. EMBO Mol. Med. 5, 456-470. doi: 10.1002/emmm.201201683
81. Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147.
82. Ratman, D., Vanden Berghe, W., Dejager, L., Libert, C., Tavernier, J., Beck, I. M., et al. (2013). How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering. Mol. Cell. Endocrinol. 380, 41-54. doi: 10.1016/j.mce.2012.12.014
83. Ray, K. P., Farrow, S., Daly, M., Talabot, F., and Searle, N. (1997). Induction of the E-selectin promoter by interleukin 1 and tumour necrosis factor alpha, and inhibition by glucocorticoids. Biochem. J. 328(Pt 2), 707-715.
84. Rea, D., van Kooten, C., van Meijgaarden, K. E., Ottenhoff, T. H., Melief, C. J., and Offringa, R. (2000). Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10. Blood 95, 3162-3167.
85. Reichardt, H. M., Tuckermann, J. P., Gottlicher, M., Vujic, M., Weih, F., Angel, P., et al. (2001). Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. EMBO J. 20, 7168-7173. doi: 10.1093/emboj/20.24.7168
86. Rhen, T., and Cidlowski, J. A. (2005). Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. N. Engl. J. Med. 353, 1711-1723. doi: 10.1056/NEJMra050541
87. Romero, Y., Vuandaba, M., Suarez, P., Grey, C., Calvel, P., Conne, B., et al. (2012). The Glucocorticoid-induced leucine zipper (GILZ) Is essential for spermatogonial survival and spermatogenesis. Sex Dev. 6, 169-177. doi: 10.1159/000338415
88. Schacke, H., Berger, M., Rehwinkel, H., and Asadullah, K. (2007). Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index. Mol. Cell. Endocrinol. 275, 109-117. doi: 10.1016/j.mce.2007.05.014
89. Schacke, H., Rehwinkel, H., and Asadullah, K. (2005). Dissociated glucocorticoid receptor ligands: compounds with an improved therapeutic index. Curr. Opin. Investig. Drugs 6, 503-507.
90. Sentman, C. L., Shutter, J. R., Hockenbery, D., Kanagawa, O., and Korsmeyer, S. J. (1991). bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67, 879-888.
91. Shi, X. M., Blair, H. C., Yang, X., McDonald, J. M., and Cao, X. (2000). Tandem repeat of C/EBP binding sites mediates PPARgamma2 gene transcription in glucocorticoid-induced adipocyte differentiation. J. Cell. Biochem. 76, 518-527. doi: 10.1002/(SICI)1097-4644(20000301)76:3<518::AID-JCB18>3.0.CO;2-M
92. Shi, X., Shi, W., Li, Q., Song, B., Wan, M., Bai, S., et al. (2003). A glucocorticoid-induced leucine-zipper protein, GILZ, inhibits adipogenesis of mesenchymal cells. EMBO Rep. 4, 374-380. doi: 10.1038/sj.embor.embor805
93. Soundararajan, R., Wang, J., Melters, D., and Pearce, D. (2007). Differential activities of glucocorticoid-induced leucine zipper protein isoforms. J. Biol. Chem. 282, 36303-36313. doi: 10.1074/jbc.M707287200
94. Srinivasan, M., and Janardhanam, S. (2011). Novel p65 binding glucocorticoid-induced leucine zipper peptide suppresses experimental autoimmune encephalomyelitis. J. Biol. Chem. 286, 44799-44810. doi: 10.1074/jbc.M111.279257
95. Steer, J. H., Kroeger, K. M., Abraham, L. J., and Joyce, D. A. (2000). Glucocorticoids suppress tumor necrosis factor-alpha expression by human monocytic THP-1 cells by suppressing transactivation through adjacent NF-kappa B and c-Jun-activating transcription factor-2 binding sites in the promoter. J. Biol. Chem. 275, 18432-18440. doi: 10.1074/jbc.M906304199
96. Suarez, P. E., Rodriguez, E. G., Soundararajan, R., Merillat, A. M., Stehle, J. C., Rotman, S., et al. (2012). The glucocorticoid-induced leucine zipper (gilz/Tsc22d3-2) gene locus plays a crucial role in male fertility. Mol. Endocrinol. 26, 1000-1013. doi: 10.1210/me.2011-1249
97. Surjit, M., Ganti, K. P., Mukherji, A., Ye, T., Hua, G., Metzger, D., et al. (2011). Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor. Cell 145, 224-241. doi: 10.1016/j.cell.2011.03.027
98. Taube, M., and Carlsten, H. (2000). Action of dexamethasone in the suppression of delayed-type hypersensitivity in reconstituted SCID mice. Inflamm. Res. 49, 548-552. doi: 10.1007/s000110050630
99. Thomas, N., Edwards, J. L., and Bell, P. A. (1983). Studies of the mechanism of glucocorticoid-induced pyknosis in isolated rat thymocytes. J. Steroid Biochem. 18, 519-524.
100. Tontonoz, P., Hu, E., and Spiegelman, B. M. (1994). Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79, 1147-1156.
101. Tsitoura, D. C., and Rothman, P. B. (2004). Enhancement of MEK/ERK signaling promotes glucocorticoid resistance in CD4+ T cells. J. Clin. Invest. 113, 619-627. doi: 10.1172/JCI18975
102. Unger, W. W., Laban, S., Kleijwegt, F. S., van der Slik, A. R., and Roep, B. O. (2009). Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1. Eur. J. Immunol. 39, 3147-3159. doi: 10.1002/eji.200839103
103. Vacca, A., Felli, M. P., Farina, A. R., Martinotti, S., Maroder, M., Screpanti, I., et al. (1992). Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements. J. Exp. Med. 175, 637-646.
104. Vandevyver, S., Dejager, L., Tuckermann, J., and Libert, C. (2013). New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation. Endocrinology 154, 993-1007. doi: 10.1210/en.2012-2045
105. Wang, W., Wykrzykowska, J., Johnson, T., Sen, R., and Sen, J. (1999). A NF-kappa B/c-myc-dependent survival pathway is targeted by corticosteroids in immature thymocytes. J. Immunol. 162, 314-322.
106. Wang, Y., Ma, Y. Y., Song, X. L., Cai, H. Y., Chen, J. C., Song, L. N., et al. (2012). Upregulations of glucocorticoid-induced leucine zipper by hypoxia and glucocorticoid inhibit proinflammatory cytokines under hypoxic conditions in macrophages. J. Immunol. 188, 222-229. doi: 10.4049/jimmunol.1002958
107. Weinstein, D. S., Gong, H., Doweyko, A. M., Cunningham, M., Habte, S., Wang, J. H., et al. (2011). Azaxanthene based selective glucocorticoid receptor modulators: design, synthesis, and pharmacological evaluation of (S)-4-(5-(1-((1,3,4-thiadiazol-2-yl)amino)-2-methyl-1-oxopropan-2-yl)-5H-chromeno [2,3-b]pyridin-2-yl)-2-fluoro-N,N-dimethylbenzamide (BMS-776532) and its methylene homologue (BMS-791826). J. Med. Chem. 54, 7318-7333. doi: 10.1021/jm200879j
108. Weinstein, R. S., Jilka, R. L., Parfitt, A. M., and Manolagas, S. C. (1998). Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J. Clin. Invest. 102, 274-282. doi: 10.1172/JCI2799
109. Yang, Y. H., Aeberli, D., Dacumos, A., Xue, J. R., and Morand, E. F. (2009). Annexin-1 regulates macrophage IL-6 and TNF via glucocorticoid-induced leucine zipper. J. Immunol. 183, 1435-1445. doi: 10.4049/jimmunol.0804000
110. Yang, Y. H., Morand, E. F., Getting, S. J., Paul-Clark, M., Liu, D. L., Yona, S., et al. (2004). Modulation of inflammation and response to dexamethasone by Annexin 1 in antigen-induced arthritis. Arthritis Rheum. 50, 976-984. doi: 10.1002/art.20201
111. Yang, Y. H., Morand, E., and Leech, M. (2013). Annexin A1: potential for glucocorticoid sparing in RA. Nat. Rev. Rheumatol. 9, 595-603. doi: 10.1038/nrrheum.2013.126
112. Yang, Y., Mercep, M., Ware, C. F., and Ashwell, J. D. (1995). Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids. J. Exp. Med. 181, 1673-1682.
113. Yao, W., Cheng, Z., Busse, C., Pham, A., Nakamura, M. C., and Lane, N. E. (2008). Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: a longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice. Arthritis Rheum. 58, 1674-1686. doi: 10.1002/art.23454
114. Zacharchuk, C. M., Mercep, M., Chakraborti, P. K., Simons, S. S. Jr., and Ashwell, J. D. (1990). Programmed T lymphocyte death. Cell activation- and steroid-induced pathways are mutually antagonistic. J. Immunol. 145, 4037-4045.
115. Zhang, W., Yang, N., and Shi, X. M. (2008). Regulation of mesenchymal stem cell osteogenic differentiation by glucocorticoid-induced leucine zipper (GILZ). J. Biol. Chem. 283, 4723-4729. doi: 10.1074/jbc.M704147200